TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL July 26, 2013